Solvent exposure in a shoe upper factory.

Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure. Br J Ind Med (1981) 1.15

n-Hexane metabolism in occupationally exposed workers. Br J Ind Med (1984) 1.05

Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine. Br J Ind Med (1986) 0.88

Value of the simultaneous determination of PCO2 in monitoring exposure to 1,1,1-trichloroethane by breath analysis. Br J Ind Med (1982) 0.82

N-N-dimethylformamide concentration in environmental and alveolar air in an artificial leather factory. Br J Ind Med (1980) 0.78

Isopropanol exposure: environmental and biological monitoring in a printing works. Br J Ind Med (1983) 0.77

Comparison of unchanged n-hexane in alveolar air and 2,5-hexanedione in urine for the biological monitoring of n-hexane exposure in human volunteers. Int Arch Occup Environ Health (2004) 0.75

[A century of industrial medicine in Italy: the opportunity of a debate for relaunching the discipline]. Med Lav (2000) 2.64

Hydrocarbon exposure and Parkinson's disease. Neurology (2000) 1.70

Long-term exposure to "low levels" of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology (1999) 1.56

Effects of inhalable particulate matter on blood coagulation. J Thromb Haemost (2009) 1.34

Trace element reference values in tissues from inhabitants of the European community. I. A study of 46 elements in urine, blood and serum of Italian subjects. Sci Total Environ (1990) 1.33

Partition coefficients of some industrial aliphatic hydrocarbons (C5-C7) in blood and human tissues. Br J Ind Med (1985) 1.32

Environmental and occupational exposure to benzene by analysis of breath and blood. Br J Ind Med (1988) 1.31

Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand J Work Environ Health (1995) 1.23

Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure. Br J Ind Med (1981) 1.15

Urinary excretion of n-hexane metabolites in rats and humans. Int Arch Occup Environ Health (1979) 1.10

Toluene concentrations in the blood and alveolar air of workers during the workshift and the morning after. Br J Ind Med (1986) 1.03

Biomonitoring of industrial solvent exposures in workers' alveolar air. Int Arch Occup Environ Health (1980) 1.02

Methyl ethyl ketone exposure in industrial workers. Uptake and kinetics. Int Arch Occup Environ Health (1984) 0.99

Alveolar air and blood dichloromethane concentration in shoe sole factory workers. Int Arch Occup Environ Health (1977) 0.99

Reference values for blood benzene in the occupationally unexposed general population. Int Arch Occup Environ Health (1992) 0.99

Sperm count and chromatin structure in men exposed to inorganic lead: lowest adverse effect levels. Occup Environ Med (2002) 0.98

Identification of the metabolites of n-hexane, cyclohexane, and their isomers in men's urine. Toxicol Appl Pharmacol (1980) 0.97

Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy. Clin Cancer Res (1996) 0.97

Benzene in the blood and breath of normal people and occupationally exposed workers. Am J Ind Med (1989) 0.97

Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Commun Mass Spectrom (1998) 0.97

Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study. Am J Clin Oncol (1997) 0.95

Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey. Arch Toxicol (1982) 0.95

Cobalt, chromium and molybdenum ions kinetics in the human body: data gained from a total hip replacement with massive third body wear of the head and neuropathy by cobalt intoxication. Arch Orthop Trauma Surg (2011) 0.95

Lung uptake and metabolism of cyclohexane in shoe factory workers. Int Arch Occup Environ Health (1980) 0.94

Solvent exposure in a shoe upper factory. II. Methylcyclopentane, 2-methylpentane, and 3-methylpentane concentration in alveolar and in environmental air and in blood. Int Arch Occup Environ Health (1979) 0.94

[2,5-hexanedione in biological monitoring of occupational exposure to n-hexane]. Med Lav (1985) 0.93

Experimental neurotoxicity and urinary metabolites of the C5-C7 aliphatic hydrocarbons used as glue solvents in shoe manufacture. Clin Toxicol (1981) 0.92

The Gene-Environment Interactions in Respiratory Diseases (GEIRD) Project. Int Arch Allergy Immunol (2010) 0.92

Urinary 1-hydroxypyrene as a marker of exposure to pyrene: an epidemiological survey on a general population group. Sci Total Environ (1997) 0.92

Motor function, olfactory threshold, and hematological indices in manganese-exposed ferroalloy workers. Environ Res (1997) 0.91

Total reflection X-ray fluorescence (TXRF) for direct analysis of aerosol particle samples. Environ Technol (2010) 0.91

Biomonitoring of occupational toluene exposure. Int Arch Occup Environ Health (1982) 0.90

Measurement of the urinary metabolites of N-hexane, cyclohexane and their isomers by gas chromatography. Int Arch Occup Environ Health (1981) 0.90

The validity of urinary metabolites as indicators of low exposures to toluene. Int Arch Occup Environ Health (1985) 0.90

Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine. Br J Ind Med (1986) 0.88

[Sudden death caused by freon 22?]. Med Lav (1993) 0.88

[Environmental and biological monitoring of exposure to polycyclic aromatic hydrocarbons in workers of an electric steel foundry]. Med Lav (2006) 0.87

The utility of health education among lead workers: the experience of one program. Am J Ind Med (1993) 0.87

"Dynamic" biological exposure indexes for n-hexane and 2,5-hexanedione, suggested by a physiologically based pharmacokinetic model. Am Ind Hyg Assoc J (1990) 0.87

An improved method of analysing 2,5-hexanedione in urine. Br J Ind Med (1990) 0.86

[Risk assessment of biomechanical load for the upper limbs in housework]. Med Lav (2007) 0.86

Benzene in blood as a biomarker of low level occupational exposure. Sci Total Environ (1999) 0.86

Breath and blood levels of benzene, toluene, cumene and styrene in non-occupational exposure. Int Arch Occup Environ Health (1989) 0.86

Biological monitoring of cadmium exposure--an Italian experience. Scand J Work Environ Health (1993) 0.86

[Gas chromatographic determination of 2,5-hexanedione in the urine]. Med Lav (1987) 0.86

Biological monitoring of workers exposed to N-N-dimethylformamide. II. Dimethylformamide and its metabolites in urine of exposed workers. Int Arch Occup Environ Health (1995) 0.85

Effects of lead and manganese on the release of lysosomal enzymes in vitro and in vivo. Clin Chim Acta (1997) 0.85

Alveolar air and blood toluene concentration in rotogravure workers. Int Arch Occup Environ Health (1976) 0.85

Ethylene oxide exposure. Biological monitoring by analysis of alveolar air and blood. Int Arch Occup Environ Health (1986) 0.85

Time To Pregnancy and occupational lead exposure. Occup Environ Med (2003) 0.85

gamma-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney. Eur J Cancer (2003) 0.85

Metabolic interaction between n-hexane and toluene in vivo and in vitro. Int Arch Occup Environ Health (1982) 0.85

Work- and non-work-related eye injuries in a highly industrialized area in northern Italy: comparison between two three-year periods (1994-1996 and 2005-2007). Med Lav (2014) 0.84

Decline of blood and alveolar toluene concentration following two accidental human poisonings. Int Arch Occup Environ Health (1983) 0.84

Neurotoxicity of cobalt. Hum Exp Toxicol (2011) 0.84

Analysis of crystalline phases in airborne particulate matter by two-dimensional X-ray diffraction (XRD2). J Environ Monit (2007) 0.84

Isomer-specific activity of dichlorodyphenyltrichloroethane with estrogen receptor in adult and suckling estrogen reporter mice. Endocrinology (2002) 0.84

Target-specific action of organochlorine compounds in reproductive and nonreproductive tissues of estrogen-reporter male mice. Toxicol Appl Pharmacol (2004) 0.84

Behaviour of biological indicators of internal dose and some neuro-endocrine tests in aluminium workers. Med Lav (1990) 0.84

Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance. Biochem Pharmacol (1998) 0.84

Benzene in environmental air and human blood. Int Arch Occup Environ Health (1998) 0.83

Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry. Rapid Commun Mass Spectrom (1998) 0.83

Poor metabolization of n-hexane in Parkinson's disease. J Neurol (2003) 0.83

The reproductive toxicity and carcinogenicity of lead: a critical review. Am J Ind Med (2000) 0.83

[Urban air pollutant exposure among traffic policemen]. Med Lav (1997) 0.83

[Survey on educational needs in occupational medicine in Italy]. G Ital Med Lav Ergon (2004) 0.82

Biochemical and physiological aspects of 2,5-hexanedione: endogenous or exogenous product? Int Arch Occup Environ Health (1993) 0.82

Hippuric acid and ortho-cresol as biological indicators of occupational exposure to toluene. Am J Ind Med (1987) 0.82

[Behavior of urinary D-glucaric acid in occupational exposure to inorganic lead]. Med Lav (1988) 0.82